|Place Of Origin:||China (Mainland)||Brand Name:||BBCA|
|Other Names:||Pharmaceutical Grade Cilnidipine Tablets||Grade:||Medicine Grade|
Pharmaceutical Grade Cilnidipine Tablets Dual L-/N-Type Calcium Channel Protein Inhibitor And Blocker
Cilnidipine is a dual L-/N-type calcium channel protein inhibitor and blocker. Cilnidipine has displayed renal and vascular protective effects and improved baroreflex sensitivity in patients with hypertension. It has also demonstrated neuroprotective effects in a rat focal brain ischemia model by removing free radicals and activating the phosphatidylinositol 3-kinase pathway.
Type: Calcium Antagonists
Usage: Treatment for hypertension patients
Manufacture: ANHUI BBCA PHARMRACEUTICAL Co., Ltd.
Hypersensitivity to Cilnidipine Tablet is a contraindication. In addition, Cilnidipine Tablet should not be used if you have the following conditions:
Acute myocardial infarction
Preexisting heart conditions